Buy Humulin® R (Regular) 100IU/ml 5x3ml injection cartridge
1 ml of solution contains 100 IU of human insulin.
Solution for injection 3 ml in a cartridge – 5 cartridges in a blister and in a cardboard box.
DNA recombinant human insulin. It is a short-acting insulin preparation.
The main action of the drug is the regulation of glucose metabolism. In addition, it has an anabolic effect. In muscle and other tissues (with the exception of the brain), insulin causes rapid intracellular transport of glucose and amino acids, accelerates protein anabolism. Insulin promotes the conversion of glucose to glycogen in the liver, inhibits gluconeogenesis, and stimulates the conversion of excess glucose to fat.
Indication for use:
diabetes mellitus in the presence of indications for insulin therapy;
newly diagnosed diabetes mellitus;
pregnancy with type 2 diabetes mellitus (non-insulin dependent).
Method of administration and dosage:
The dose is determined by the doctor individually, depending on the level of glycemia.
The drug should be administered subcutaneously, intravenously, possibly intramuscularly.
S / C the drug is injected into the shoulder, thigh, buttocks or abdomen. The injection site must be alternated so that the same site is used no more than about 1 time / month.
When administered subcutaneously, care must be taken to avoid entering the blood vessel. After injection, do not massage the injection site. Patients should be trained in the correct use of insulin delivery devices.
Humulin Regular in the cartridge does not require resuspension and can only be used if their content is a clear, colorless liquid without visible particles.
Do not use the drug if it contains flakes, if hard white particles adhere to the bottom or walls of the bottle, creating the effect of a frosty pattern.
The cartridge does not allow mixing of its contents with other insulins directly in it. The cartridge is not refillable.
The cartridge must not be used by others. Use the cartridges until they are empty and then discard them.
– hypersensitivity to insulin or to one of the components of the drug.
The transfer of a patient to another type of insulin or to an insulin preparation with a different trade name should be carried out under strict medical supervision. Changes in insulin activity, type (eg, M3, NPH), species (porcine, human insulin, human insulin analog) or production method (DNA recombinant insulin or animal insulin) may necessitate dose adjustments.
The need for dose adjustment may be required as early as the first administration of a human insulin preparation after an animal insulin preparation, or gradually over several weeks or months after transfer.
Influence on the ability to drive vehicles and control mechanisms: during hypoglycemia, the patient’s ability to concentrate may deteriorate and the speed of psychomotor reactions may decrease. This can be dangerous in situations in which these abilities are especially needed (driving a car or operating machinery). Patients should be advised to take precautions to avoid hypoglycemia while driving. This is especially important for patients with mild or absent symptoms that predict hypoglycemia or with frequent hypoglycemia. In such cases, the physician should assess the appropriateness of the patient’s driving.
The drug should be stored in a refrigerator at a temperature of 2 ° to 8 ° C, avoid freezing, keep away from direct exposure to light. Shelf life is 2 years.
The drug in use in a vial or cartridge should be stored at room temperature (15 ° to 25 ° C) for no more than 28 days.